Hepatitis B immune globulin to prevent non-A, non-B post-transfusion hepatitis. 1985

U Sugg, and W Schneider, and H E Hoffmeister, and C Huth, and W Stephan, and R Lissner, and W Haase

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D006525 Hepatitis, Viral, Human INFLAMMATION of the LIVER in humans due to infection by VIRUSES. There are several significant types of human viral hepatitis with infection caused by enteric-transmission (HEPATITIS A; HEPATITIS E) or blood transfusion (HEPATITIS B; HEPATITIS C; and HEPATITIS D). Viral Hepatitis, Human,Human Viral Hepatitides,Human Viral Hepatitis,Viral Hepatitides, Human
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D014761 Viral Hepatitis Vaccines Any vaccine raised against any virus or viral derivative that causes hepatitis. Hepatitis, Viral, Vaccines,Hepatitis Vaccines, Viral,Vaccines, Viral Hepatitis
D017325 Hepatitis B Vaccines Vaccines or candidate vaccines containing inactivated hepatitis B or some of its component antigens and designed to prevent hepatitis B. Some vaccines may be recombinantly produced. Hepatitis B Vaccine,Vaccine, Hepatitis B,Vaccines, Hepatitis B
D065227 Transfusion Reaction Complications of BLOOD TRANSFUSION. Included adverse reactions are common allergic and febrile reactions; hemolytic (delayed and acute) reactions; and other non-hemolytic adverse reactions such as infections and adverse immune reactions related to immunocompatibility. Delayed Hemolytic Transfusion Reaction,Acute Hemolytic Transfusion Reaction,Blood Transfusion-Associated Adverse Reactions,Delayed Serologic Transfusion Reaction,Febrile Non-Hemolytic Transfusion Reaction,Hemolytic Transfusion Reaction,Hypotensive Transfusion Reaction,Post-Transfusion Purpura,Posttransfusion Purpura,TAGHD,Transfusion-Associated Allergic Reaction,Transfusion-Associated Circulatory Overload,Transfusion-Associated Dyspnea,Transfusion-Associated Graft Vs. Host Disease,Transfusion-Transmitted Infection,Allergic Reaction, Transfusion-Associated,Blood Transfusion Associated Adverse Reactions,Circulatory Overload, Transfusion-Associated,Circulatory Overloads, Transfusion-Associated,Dyspnea, Transfusion-Associated,Febrile Non Hemolytic Transfusion Reaction,Hemolytic Transfusion Reactions,Infection, Transfusion-Transmitted,Post Transfusion Purpura,Posttransfusion Purpuras,Purpura, Post-Transfusion,Purpura, Posttransfusion,Reaction, Hemolytic Transfusion,Reaction, Hypotensive Transfusion,Reactions, Hemolytic Transfusion,Transfusion Associated Allergic Reaction,Transfusion Associated Circulatory Overload,Transfusion Associated Dyspnea,Transfusion Associated Graft Vs. Host Disease,Transfusion Reaction, Hemolytic,Transfusion Reaction, Hypotensive,Transfusion Reactions,Transfusion Reactions, Hemolytic,Transfusion Reactions, Hypotensive,Transfusion Transmitted Infection,Transfusion-Associated Circulatory Overloads,Transfusion-Transmitted Infections

Related Publications

U Sugg, and W Schneider, and H E Hoffmeister, and C Huth, and W Stephan, and R Lissner, and W Haase
April 1967, Iryo,
U Sugg, and W Schneider, and H E Hoffmeister, and C Huth, and W Stephan, and R Lissner, and W Haase
March 1978, Lancet (London, England),
U Sugg, and W Schneider, and H E Hoffmeister, and C Huth, and W Stephan, and R Lissner, and W Haase
October 1989, Rinsho byori. The Japanese journal of clinical pathology,
U Sugg, and W Schneider, and H E Hoffmeister, and C Huth, and W Stephan, and R Lissner, and W Haase
March 1976, Lancet (London, England),
U Sugg, and W Schneider, and H E Hoffmeister, and C Huth, and W Stephan, and R Lissner, and W Haase
March 1977, Lancet (London, England),
U Sugg, and W Schneider, and H E Hoffmeister, and C Huth, and W Stephan, and R Lissner, and W Haase
June 1987, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
U Sugg, and W Schneider, and H E Hoffmeister, and C Huth, and W Stephan, and R Lissner, and W Haase
September 1984, Orvosi hetilap,
U Sugg, and W Schneider, and H E Hoffmeister, and C Huth, and W Stephan, and R Lissner, and W Haase
December 1988, Nihon rinsho. Japanese journal of clinical medicine,
U Sugg, and W Schneider, and H E Hoffmeister, and C Huth, and W Stephan, and R Lissner, and W Haase
January 1991, Scandinavian journal of thoracic and cardiovascular surgery,
U Sugg, and W Schneider, and H E Hoffmeister, and C Huth, and W Stephan, and R Lissner, and W Haase
October 1988, Revue francaise de transfusion et immuno-hematologie,
Copied contents to your clipboard!